Skip to main content
. 2016 Jan 12;3:190–201. doi: 10.1016/j.toxrep.2016.01.007

Fig. 7.

Fig. 7

Plasma; The concentration of TBBPA-S and TBBPA-GA at 4 h following 7, 14, and 28 days of consecutive dosing. Each bar represents the mean ± SD (n = 4–6 per group). (*) indicates a significant dose-related increasing trend in TBBPA-GA and TBBPA-S at A 7, B 14, and C 28-days of dosing (p < 0.01). (^) indicates a significantly higher concentration of TBBPA-GA compared to TBBPA-S at each dose level (p < 0.05).